Omadacycline tosylate is a tetracycline-class antibiotic used to treat bacterial infections. It is effective against a broad range of bacteria, including those resistant to other antibiotics. This makes it particularly valuable in treating acute bacterial skin and skin structure infections (ABSSSI), as well as community-acquired bacterial pneumonia (CABP). Its broad-spectrum activity allows it to target both Gram-positive and Gram-negative bacteria. The medication is administered intravenously or orally, providing flexibility in treatment options for patients. It is often prescribed when other antibiotics have failed or are not suitable due to resistance or allergy concerns.